
Dexcom Inc (DXCM) Stock: Assessing the Risk and Reward
In the past week, DXCM stock has gone up by 16.77%, with a monthly gain of 35.24% and a quarterly plunge of -6.12%. The volatility
In the past week, DXCM stock has gone up by 16.77%, with a monthly gain of 35.24% and a quarterly plunge of -6.12%. The volatility
Dexcom Inc (NASDAQ: DXCM)’s stock price has soared by 16.17 in relation to previous closing price of 70.26. Nevertheless, the company has seen a gain
Dexcom Inc (NASDAQ: DXCM) has a price-to-earnings ratio of 49.96x that is above its average ratio. Additionally, the 36-month beta value for DXCM is 1.43.
The stock of Dexcom Inc (NASDAQ: DXCM) has decreased by -3.59 when compared to last closing price of 68.57.Despite this, the company has seen a
Dexcom Inc (NASDAQ: DXCM) has a higher price-to-earnings ratio of 47.30x compared to its average ratio, The 36-month beta value for DXCM is at 1.43.
Dexcom Inc (NASDAQ: DXCM) has seen a rise in its stock price by 3.01 in relation to its previous close of 59.83. However, the company
Dexcom Inc (NASDAQ: DXCM) has a higher price-to-earnings ratio of 47.94x compared to its average ratio. DXCM has 36-month beta value of 1.51. Analysts have
In the past week, DXCM stock has gone up by 4.03%, with a monthly decline of -18.95% and a quarterly plunge of -2.99%. The volatility
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.